RBC Capital analyst Anton Hie maintained a Buy rating on AdaptHealth (NASDAQ:AHCO) on Wednesday, setting a price target of $36, which is approximately 22.91% above the present share price of $29.29.
Hie expects AdaptHealth to post earnings per share (EPS) of $0.09 for the fourth quarter of 2020.
The current consensus among 4 TipRanks analysts is for a Strong Buy rating of shares in AdaptHealth, with an average price target of $33.88.
The analysts price targets range from a high of $36 to a low of $32.5.
In its latest earnings report, released on 06/30/2020, the company reported a quarterly revenue of $232.12 million and a net profit of $16.47 million. The company's market cap is $2.47 billion.
According to TipRanks.com, RBC Capital analyst Anton Hie is currently ranked with 4 stars on a 0-5 stars ranking scale, with an average return of 21.0% and a 66.67% success rate.
AdaptHealth Corp. provides medical products for both rental and sale. It focuses on respiratory and/or mobility equipment, including CPAP sleep equipment, oxygen equipment, wheelchairs, walkers, and hospital beds. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.